Article
A p75 tumor necrosis factor receptor-specific mutant of murine tumor necrosis factor alpha expressed from an adenovirus vector induces an antitumor response with reduced toxicity.
Cancer gene therapy - 1 Jan 2000
Marr R A, Hitt M, Gauldie J, Muller W J, Graham F L
Abstract excerpt
The toxic effects of tumor necrosis factor alpha (TNFalpha) have greatly limited its use in tumor therapy. Recently, clear evidence has been obtained linking the p55 TNF receptor (TNFR) to the induction of systemic toxicity. We have generated a p75 murine TNFR (mTNFR)-specific mutant of mTNFalpha (D142N-A144R), cloned this gene into a recombinant adenovirus vector (Ad-75), and studied its efficacy for tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
